We also demonstrated that misexpression of the levels of TMEM230 and RNASET2 contributed to aggressive cancer features, including aberrant angiogenesis and destructive tissue remodeling, and a loss of normal cell-to-cell and cell-to-substratum attachments. Here, RNASET2 is linked to cancer.